HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sebastian Klobuch Selected Research

Rituximab (Mabthera)

10/2019Long-term follow-up of rituximab in treatment of chronic graft-versus-host disease-single center experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sebastian Klobuch Research Topics

Disease

11Neoplasms (Cancer)
05/2022 - 06/2010
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018 - 01/2015
4Leukemia
01/2022 - 01/2018
3Hodgkin Disease (Hodgkin's Disease)
10/2019 - 08/2015
3Infections
10/2019 - 12/2012
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 01/2014
2Bronchiolitis Obliterans Syndrome
04/2020 - 10/2019
2Hematologic Diseases (Blood Diseases)
10/2019 - 01/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021
1Lung Neoplasms (Lung Cancer)
01/2021
1Disease Progression
01/2021
1Inflammation (Inflammations)
01/2019
1Anemia
01/2018
1Breast Neoplasms (Breast Cancer)
01/2018
1Poisoning
01/2018
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2018
1Melanoma (Melanoma, Malignant)
11/2016
1Carcinoma (Carcinomatosis)
08/2015
1Prostatic Neoplasms (Prostate Cancer)
08/2015
1Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
08/2015
1Multiple Myeloma
08/2015
1Virus Diseases (Viral Diseases)
01/2014
1Herpes Zoster
06/2012

Drug/Important Bio-Agent (IBA)

4T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2018 - 06/2010
2Lactic Acid (Lactate)FDA LinkGeneric
05/2022 - 11/2016
2HLA-DP Antigens (HLA-DP)IBA
01/2022 - 01/2018
2Pioglitazone (Actos)FDA Link
01/2021 - 01/2018
2AntigensIBA
01/2020 - 01/2018
2Indicators and Reagents (Reagents)IBA
01/2020 - 12/2012
2Biological ProductsIBA
01/2019 - 01/2018
2Drug CombinationsIBA
01/2018 - 01/2018
2Azacitidine (5 Azacytidine)FDA Link
01/2018 - 01/2018
2Neoplasm Antigens (Tumor Antigens)IBA
04/2016 - 06/2010
1Protons (Proton)IBA
05/2022
1treosulfanIBA
01/2021
1NivolumabIBA
01/2021
1Clarithromycin (Biaxin)FDA LinkGeneric
01/2021
1PlatinumIBA
01/2021
1tocilizumab (atlizumab)FDA Link
04/2020
1HLA-DPB1 antigen (HLA DPB1)IBA
01/2020
1Rituximab (Mabthera)FDA Link
10/2019
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2018
1Immunomodulating AgentsIBA
01/2018
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2018
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2018
1Cytotoxins (Cytolysins)IBA
01/2018
1Diclofenac (SR 38)FDA LinkGeneric
01/2018
1Diflunisal (Dolobid)FDA Link
01/2018
1Pharmaceutical PreparationsIBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1Hemoglobins (Hemoglobin)IBA
01/2018
1Metformin (Glucophage)FDA LinkGeneric
01/2018
1Methotrexate (Mexate)FDA LinkGeneric
01/2018
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2018
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2018
1Blocking AntibodiesIBA
01/2017
1Lactate Dehydrogenase 5IBA
11/2016
1EpitopesIBA
07/2015
1Peptides (Polypeptides)IBA
07/2015
1Chimeric Antigen ReceptorsIBA
01/2014
1RNA (Ribonucleic Acid)IBA
12/2012
1Subunit VaccinesIBA
06/2012
1Glycoproteins (Glycoprotein)IBA
06/2012
1Proteins (Proteins, Gene)FDA Link
06/2012

Therapy/Procedure

11Therapeutics
05/2022 - 01/2015
5Hematopoietic Stem Cell Transplantation
04/2020 - 06/2012
4Drug Therapy (Chemotherapy)
01/2021 - 01/2017
3Stem Cell Transplantation
01/2022 - 06/2012
3Immunotherapy
01/2018 - 01/2014
2Salvage Therapy
04/2020 - 01/2018
1Transplantation
01/2020
1Castration
08/2015
1Homologous Transplantation
06/2012